Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013;17(3):250-6.
doi: 10.5114/wo.2013.35278. Epub 2013 Jun 28.

Expression of β-catenin and AXIN2 in ameloblastomas

Affiliations

Expression of β-catenin and AXIN2 in ameloblastomas

Zhenhui Wei et al. Contemp Oncol (Pozn). 2013.

Abstract

Aim of the study: To investigate the expression status and association of β-catenin and AXIN2 in ameloblastoma.

Material and methods: 30 ameloblastoma specimens and 10 normal oral mucosa tissues were enrolled in the study. The protein and RNA levels of β-catenin and AXIN2 were detected by immunohistochemistry staining, Western blot, and real-time PCR analysis. The relationship between β-catenin and AXIN2 protein and clinico-pathological parameters and prognosis was subsequently determined.

Results: The results show that β-catenin mRNA expression was 1.24-fold higher in ameloblastomas than that in normal mucosa tissues, but AXIN2 mRNA expression was 0.47-fold lower in ameloblastomas than that in normal mucosa tissues (p < 0.05). The Western blot results show that β-catenin and AXIN2 protein in ameloblastomas had a significantly higher level than normal mucosa tissues (p < 0.05). Immunohistochemical staining of β-catenin and AXIN2 protein in ameloblastoma was expressed at a higher level than normal oral mucosa (p < 0.05).

Conclusions: AXIN2 and β-catenin play an important role in the tumorigenesis and progression of ameloblastoma.

Keywords: AXIN2; Wnt pathway; ameloblastoma; β-catenin.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Amplification and dissociation curves detected by real-time PCR; A) CTNNB1 amplification; B) CTNNB1 dissociation; C) AXIN2 amplification; D) AXIN2 dissociation curve
Fig. 2
Fig. 2
A) β-catenin expression level detected by Western blot analysis. The figures below the gel image represent the ratios of β-catenin to β-tubulin; B) AXIN2 expression level detected by Western blot analysis. The figures below the gel images represent the ratios of AXIN2 to β-tubulin
Fig. 3
Fig. 3
A) β-catenin aberrant expression in cytoplasm of ameloblastomas (20×); B) β-catenin aberrant expression in the nucleus of ameloblastomas (arrow) (40×); C) β-catenin expressed in the normal oral mucous membrane, with no aberrant expression in cytoplasm and nucleus (20×); D) AXIN2 is expressed in ameloblastomas (20×); E) AXIN2 is expressed in ameloblastomas (40×); F) AXIN2 is expressed in the normal oral mucous membrane (20×)

References

    1. Luo HY, Li TJ. Odontogenic tumors: a study of 1309 cases in a Chinese population. Oral Oncol. 2009;45:706–11. - PubMed
    1. Sailer HF, Tarawneh F, Fourkas P, Antoniades DZ, Athanasiou AE. Surgical, orthodontic and prosthodontic rehabilitation of a patient with follicular ameloblastoma: a case report. Eur J Dent. 2010;4:192–6. - PMC - PubMed
    1. Adekeye EO, Lavery KM. Recurrent ameloblastoma of the maxillo-facial region. Clinical features and treatment. J Maxillofac Surg. 1986;14:153–7. - PubMed
    1. Ghandhi D, Ayoub AF, Pogrel MA, MacDonald G, Brocklebank LM, Moos KF. Ameloblastoma: a surgeon's dilemma. J Oral Maxillofac Surg. 2006;64:1010–4. - PubMed
    1. Carlson ER, Marx RE. The ameloblastoma: primary, curative surgical management. J Oral Maxillofac Surg. 2006;64:484–94. - PubMed

LinkOut - more resources